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THE ROLE OF ANTIDIURETIC HORMONE IN CORTICOTROPHIN RELEASE**
The possibility that the posterior lobe of the pituitary may provide the
neuroglandular link for activation of the anterior lobe was entertained by
Hensey and Markee as early as 1933 when they postulated that "the path-
ways from the hypothalamus must activate the posterior lobe of the hypo-
physis which in turn may exert an influence on the anterior lobe by hormonal
transmission."' This relationship has become of more than theoretical in-
terest since vascular links between the anterior and posterior pituitary glands
have been demonstrated in the rat,'8 dog," rabbit, cat, guinea pig,'7 and man.'
The functional significance of these interlobar vessels has been demonstrated
by their ability to maintain the integrity of a significant volume of anterior
pituitary following infarction of the stalk of the anterior lobe in the rat,
sheep, goat, baboon, rhesus monkey, and man.10
At the present time, evidence has been advanced to demonstrate a role of
the neurohypophysis in the control of luteotrophic,' thyrotrophic,'somato-
trophic,1' and adrenocorticotrophic hormone release. The evidence that
ACTH may be regulated by the neurohypophysis lies along three lines: (i)
the administration of exogenous vasopressin results in ACTH discharge;
(ii) ADH and ACTH are released or inhibited simultaneously; and (iii)
the posterior pituitary is essential for the release of ACTH.
Stimulation of ACTH release by exogenous ADH. The repeatedly
observed effect of exogenous vasopressin upon adrenal activation is the
best documented of the arguments for its role in ACTH release. The
effect of posterior lobe extracts upon the adrenal cortex was first noted
by opotherapists. Baduel, as early as 1908, noted adrenal cortical pro-
liferation resulting from administration of succo de lobo posteriore ipofi-
surie.' In the following year Delille published results of experiments often
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said to be the first to demonstrate the corticotrophic effect of the pituitary
gland. It is not generally appreciated that he attributed this activity to the
posterior pituitary. He demonstrated that the administration of either whole
extract or posterior pituitary extract doubled adrenal weight, caused hyper-
plasia of adrenal cortex, and produced pituitary basophilia' (confirmed by
Martini et al. 1956.u
The investigations of the opotherapist lay fallow for more than twodecades
until their studies were confirmed by several investigators seeking to find
in the pressor activity of the posterior lobe a possible etiology of vascular
disease. Moehling and Osius in 1931 and Hantschmann in 1937 noted the
hypertrophy of the zona fasciculata of the suprarenal cortex in response to
vasopressor fractions of the pars neuralis.`M In 1935 Moszkowska noted
the presence of corticotrophic activity of the pars neuralis when injected
into normal rabbits. She attributed this to diffusion of colloid containing
ACTH from the anterior lobe.'
In his attempts at ACTH purification Sayers noted in 1943 that poste-
rior lobe contamination of ACTH produced an additive adrenal response
in the normal animal. This effect was localized in the vasopressin fraction
and was abolished by hypophysectomy of the recipient animal.' Parks some
eight years later also remarked about this property of the posterior lobe
extracts.7"
The first intensive investigation of this activity of vasopressin was pub-
lished by Eser and Sipahioglu who demonstrated an eosinopenia when this
material was injected into normal rats. They demonstrated that this
phenomenon was inhibited by hypophysectomy but not by unilateral adrenal-
ectomy or adrenal demedullation. On the basis of the anatomical proximity
of the pituitary lobes, they postulated that vasopressin may be one mediator
of ACTH stimulation.' In the same year Nagareda and Gaunt noted
similar adrenal activation while studying the apparent reciprocal nature of
ADH and ACTH at the renal level.'
In the following year Stutinski and his collaborators demonstrated the
posterior lobe activity in a number of commercial preparations and were
able to show that the adrenal activating activity is parallel to the vasopressor
activity, thus concluding that the property must be due to vasopressin."
At the present time there are some 25 published experiments decribing
the adrenal activation following injection of vasopressin in normal animals
(Table 1). The indices ofthis activityhave been varied: eosinopenia, anti-in-
sulin effect, adrenal weight, adrenal histology changes, adrenal content of
cholesterol and ascorbic acid, P32 uptake by the adrenal, plasma and urinary
steroids, and plasma or pituitary ACTH. The preparations of vasopressin
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TABLE 1. EFFECT OF VASOPRESSIN IN THE NORMAL ANIMAL* **
Vasopressin Dose U. Animal Index
Pitressin 7.5/15 days(SC) Rat Adrenal weight, lipid
depletion'
Pituitrin 0.28-0.5(SC) t Rat Cytochemical changes
in adrenal cortex" 91
Pitressin 1.0-5.0(IP) Rat Adrenal cholesterol
depletion
Pitressin 0.1-0.2(IP) Mouse Anti-insulin effectf"
PNH 0.83-1.66(IP)
Pitressin 0.7-1.25(IV,SC,IP) Rat Adrenal ascorbic acid
Crude VP 0.4 (SC) depletion5',4',',',',','
Purified VP 0.4 (SC)
Vasopressin
A,B,C,(?) 0.5 (SC)
Pituitrin(DNZ) 0.4 (SC)
LVP 0.3 (IP)
Saline extract (IP) Guinea Urinary neutral re-
post. pituitary pig ducing lipid'
Pitressin 3.0 (IP)
Highly purified 8.0 (IP)
Highly purified 0.13-2.12 (IC) Dog Plasma 17-OH
LVP corticoids70
Pitressin 2.0-5.5 (IV) Human Plasma 17-OH
LVN-2 2.0 (IV) corticoids'"59,9
AVN-2 2.0 (IV)
Synthetic LVP 2.0 (IV)
Pitressin 0.2 (IP) Rat Ps uptake by
adrenals'
Pitressin 2140/100 days Rabbit Adrenal weight'
(SC, IP)
Tonephin Rabbit Adrenal weight'
Vasopressin 0.2-1.0% (SC) Mouse Cytochemical changes
(DNZ) in adrenal cortex'
Post. Pit. Rabbit Adrenal weight'
extract
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TABLE 1. (Continued)
Vasopressin
Infundin
Postuitrin
Pitressin
Synthetic AVP
Pitressin
Synthetic LVP
Highly purified
AVP
Dose U.
0.005t (SC)
0.1-2xO.25 (SC)
0.01t (SC)
0.08-0.1t (IP,IV)
0.2 (IP)
0.04-0.4t (IV)
0.04t (IC)
0.08-0.2 (IC) %
0.2 (IC)%
0.002 (VNT)
0.02t (IV)
Animal Index
Rat Eosinopenia"
Rat Adrenal ascorbic acid
depletion, pituitary
ACTH content (in
vitro assay) Y
Rat Plasma ACTH activity
(adrenal ascorbic
acid assay)'
Dog Adrenal effluent 17-OH
corticoids'
*Symbols:
%-dose stated per 100 gm. body weight.
SC-subcutaneous injection.
IP-intraperitoneal injection.
IV-intravenous injection or infusion.
IM-intramuscular injection.
IC-intracarotid infusion or injection.
VNT-intraventricular injection.
t-ineffective.
local-direct application to intraocular transplant.
perf.-perfusion per minute.
VP-vasopressin.
LVP-lysine vasopressin.
AVP-arginine vasopressin.
(?)-preparation of vasopressin not stated.
LS-lymph sac of frog.
**Preparations of Vasopressin:
Pituitrin, Pitressin-trademarks of Parke-Davis.
Postipofisan-trademark of Richter.
AVN-2,3,5 arginine vasopressin purified by du Vignead.
LVN-2 lysine vasopressin purified by du Vignead.
PNH-Pars neuralis hormone prepared by Van Dyke.
Pituitrin(DNZ)-product of Dai-Nippon Zoki Institute.
Vasopressin(DNZ)-product of Dai-Nippon Zoki Institute.
Tonephin
Infundin
Postuitrin
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have ranged from posterior lobe extracts to synthetic (and therefore presum-
ablypure) arginine and lysine vasopressin. In addition it has been shown that
inactivation of the pressor activity parallels inactivation of ACTH releasing
activity.9 Although we can conclude from these studies that vasopressin
stimulates ACTH release, we must also discuss the specificity of this effect
and its physiological significance.
Because of the possibility that vasopressin may act as a nonspecific stres-
sor, preparations have been employed in which the ACTH response to var-
ious stresses has been inhibited or abolished (Table 2). The 23 published
attempts to demonstrate a specificity of response have employed various
preparations which include: the immature rat, the steroid block, the mor-
phine-nembutal block, chloropromazine block, prolonged ether anesthesia,
hypothalamic lesions, ocular pituitary transplants, decerebrate and ether
anesethetized rats, neurohypophysectomy, and pituitary stalk section.
In each of these experimental situations the preparation has shown an in-
ability to respond to one or more stressing procedures, indicating some de-
gree of isolation of the pituitary gland from its afferent stimuli. The demon-
stration that vasopressin is specifically active in these circumstances makes
the conclusion that the material acts directly upon the pituitary seem justi-
fied. This conclusion is strengthened by the observation that synthetic lysine
vasopressin has a corticotrophin releasing effect upon the pituitary in
vitro.*' It is noteworthy that the systemic doses necessary for adrenal ac-
tivation are in general the same as those used in the normal animal.
Nagureda and Gaunt were the first to question the physiological signi-
ficance of the ACTH releasing effect of vasopressin when they studied the
phenomenon in 1951. In their classic work they noted that the dose of pitres-
sin necessary for adrenal activation was 20 to 80 times that reproducing
physiological antidiuresis (0.005 units)." Shannon and later Lausen studied
the rate of ADH liberation in dog and man and found that the physiological
rate of secretion fell between 0.001 to 0.005 and 0.007 to 0.050 units respec-
tively.'9' It is readily appreciated (from Tables 1 and 2) that all of the
doses administered systemically were in excess of the physiological range.
This forms one of the serious objections to the ADH theory of pituitary
stimulation.
Although this objection to the significance of ADH in activating
the adrenal may be partially on the basis of esthetics, some attempts have
been made to quantitate the threshold necessary to produce ACTH release.
* It is pertinent to call attention to the criticisms of in vitro studies of pituitary and
adrenal stimulation. Those interested in this topic of methodology are referred to
a recent review and defense of the in vitro technique by Guillemin and Schally.8
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TABLE 2. THE EFFECT OF VASOPRESSIN IN ANIMALS BLOCKED TO STRESSB
Vasopressin Dose U. Animal Index
Immature
35/3days(IP)
25/3days(IP)
1-5 (IP)
35 (IP)
25 (IP)
Rat Adrenal hypertrophy
lipid depletion'
Rat Adrenal cholesterol
depletion'
Rat Thymus involution body
weight'
Steroid blockade
Pitressin
LVP
Highly purified
AVP
Vasopressin(?)
Pitressin
Pitressin
Pitressin
Lyophilized
Pitressin
AVN-5
Pitressin
Highly purified
Vasopressin ( ?)
0.2,0.3-2.4(IV)
1.25(IP)
0.012(IC)
0.3(IV)
0.25t(IP)
0.5-1.0(IP)
0.1
0.11(IV)
0.2t(IP)
Rat Adrenal ascorbic acid
depletionS 9.14.l5tm172,74,t
Rat
Rat
Prolonged ether anesthesia
5.0(IV,IC) Rat
5.0 (IV)
5.0 (IV)
Morphine-Nembutal block
0.07-0.2t,0.25 (IV) Rat
0.006-.04t
0.08.40
Chloropromazine block
0.1 (IV) Rat
Pituitary ATH content
(in vitro assay)'
Ptm uptake by adrenalstm
Plasma ACTH activity
(adrenal ascorbic acid
assay) 81
Adrenal ascorbic acid
depletion, plasma
corticosterone5'1,90,81,72
Adrenal ascorbic acid
depletion'm
Reserpine block
0.3(IV) Rat
Dibenzyline treated
Vasopressin( ?) 0.1 Rat
Adrenal ascorbic acid
depletion'
Adrenal ascorbic acid
depletion7'
Pitressin
PNH
Pitressin
Pitressin
PNH
Pitressin
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TABLE 2. (Continued)
Vasopressin
Pitressin
Synthetic LVP
Highly purified
LVP
Dose U. Animal
Hypothalamic Lesion
0.1,0.2,0.61 (IV) Rat
0.1 (LS)
0.004-.032* (IV)
0.064-.128 (IV)
Frog
Index
Adrenal ascorbic acid
depletion'4' 4'5 78
Molting'
Rat Plasma corticosterone'
Pituitary Transplant
0.01-0.3(IP,local) Rat
0.3(IP)
Adrenal ascorbic acid
depletion, eosino-
penia8' 5
Decerebrate and Ether Anesthesia
5.0*(IV) Rat
Neurohypophysectomized
0.3(SC) Rat
Decapitate
0.5-5(IV)
s
1
2x3days
Rat
3talk Section
Dog
Plasma ACTH (adre-
nal ascorbic acid
assay) 2
Adrenal ascorbic acid
depletion'
Plasma ACTH (adre-
nal ascorbic acid
assay)78
Blood ACTH, Plasma
17-OH corticosteroids,
Cytochemical changes
in adrenal cortex'8
In Vitro
Pitressin
Synthetic LVP
Synthetic AVP
Highly purified
LVP
Pitressin
AVN-2
Pitressin
0.0001
0.00067
0.001
0.0005
1.0
1.0-2.0
Rat Saffran-Schally
assay79'
'
Rat Tissue culture (adrenal
ascorbic acid deple-
tion)
Rat Pituitary incubation
(adrenal ascorbic
acid depletion)"2
* See Table 1 for footnotes.
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Arimura found that the threshold for pituitary activation as measured by
plasma ACTH activity fell between 0.04 and 0.08 units of vasopressin in
the rat.2 Nichols et al. have noted the threshold to be 0.16 and 0.26 units
in the dog. Using highly purified lysine vasopressin in the experiments with
unanesthetized dogs, they were able to calculate that a difference of 3.5x103
to 7.1x103 molecules/second existed between the dose reproducing physio-
logical antidiuresis and that producing ACTH release.' Knowing that the
threshold for in vitro pituitary stimulation is approximately one thousandth
of the in vivo threshold dose in the rat it can be argued that dilution may
account for the necessarily high dose required to produce a sufficient con-
centration of exogenous vasopressin at the pituitary.2"8 ""' However, by the
same reasoning, the endogenous vasopressin would have to reach this level
to stimulate ACTH release. This would dictate a maximal antidiuresis each
time ACTH is discharged. Such a parallel discharge of vasopressin has not
been observed experimentally in unanesthetized hydrated dogs' sensitive
to as little as one or two milliunits of purified lysine vasopressin. In view
of this observation and the enormous doses of exogenous vasopressin, it can
only be concluded that the physiological significance of the ACTH releasing
and adrenal-stimulating potential of the posterior lobe hormone is very
hypothetical.
The necessary confirmation of the site of vasopressin activity lies in the
demonstration that the posterior lobe hormone has no direct effect upon the
adrenal. This was assumed to be clearly established by earlier students of
this relationship who found no adrenal activation when the indices of thymic
involution, eosinopenia, adrenal weight and content of lipid, cholesterol or
ascorbic acid, and peripheral plasma or urinary steroids have been used
(Table 3). Using the most direct approach to the problem, Nelson and
Hume in 1957 and Hilton in 1959 studied the effect of vasopressin on
adrenal venous effluent steroid content. Working with hypophysectomized
dogs, Nelson and Hume found that giving 0.2 to 20 units intravenously
stimulated corticogenesis.' Hilton, using the isolated dog adrenal perfused
by hypophysectomized donor blood, found that the addition of as little as
0.00001 ,u/ml. to the perfusing blood stimulated corticogenesis.' Hilton's
apparently logical conclusion that ADH may participate in adrenal activa-
tion at the adrenal level may be premature. Lipscomb et al. have extended
these original observations and have found that such a direct effect of
vasopressin on the adrenal is absent in the in vivo or in vitro rat adrenal.0
This finding confirms the specificity of ADH for anterior pituitary activa-
tion in the rat but does not explain Hilton's observations in the dog. In
further studies Lipscomb et al. confirmed the responsiveness of the dog
adrenal to vasopressin but discovered that the necessary dose was 2 x 10'
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TABLE 3. THE EFFECT OF VASOPRESSIN IN THE HYPOPHYSECTOMIZED ANIMAL*
Vasopressin
Pitressin
Pitressin
Pitressin
Pitressin
Pitressin
Postipofisan
Pitressin
Dose U.
1.6(IV)t
5 (IP)t
0.3 (SC) t
0.2(IV)t
0.S(SC)t
0.2(SC)t
0.3(IP)t
Animal
Rat
Rat
Index
Adrenal ascorbic acid
depletion (64%
block)7'
Adrenal ascorbic acid
depletion (92-98%o
block) ', 5
Rat Adrenal ascorbic acid
depletion (100%
block)lun,, ,
Rat
Rat
0.3(IP)t
7.5/15 days(SC)t Rat
Adrenal ascorbic acid
depletion (100%
block)'
Eosinopenia (100%
block)55 Adrenal as-
corbic acid depletion
(99% block)
Adrenal weight lipid
depletion (100%
block)
'
Guinea Urinary neutral reduc-
pig ing lipid (100%
block)59
Pitressin
AVN-5
Synthetic AVP
Pitressin
PNH
Pitressin
PNH
Pitressin
PNH
Pitressin
Purified VP
Synthetic VP
1-5(IV)
2.5-5(IV)
1-5(IV)
lx14 days(IP)t
75x 3 days(IP)t
833x14 days(IP)t
lx14 days(IP)t
75x 3 days(IP)t
833x14 days(IP)t
1(IP)t
833(IP)t
0.2-20(IV)
Rat
Rat
Rat
Rat
Dog
Adrenal ascorbic acid
depletion7'
Adrenal weight, lipid
maintenance'5
Adrenal cholesterol
depletion55
Thymic involution'5
Adrenal vein 17-OH
corticoids'
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TABLE 3. (Continued)
Vasopressin Dose U. Animal Index
Synthetic VP 0.1-0.4(perf) Dog In situ perfusion of
adrenal, 17-OH corti-
coids'
Pitressin 0.2t(IP) Rat P' uptake of adrenals
(64% block)
AVP 0.3t(IV) Rat Plasma free cortico-
sterone'
Infundin 2x0.02t Rat Eosinopenia'
Post. Pit. 300-600/13 days Rat Adrenal hypertrophy"
extract
Pitressin 1.0-4.0 Rat Adrenal ascorbic acid
depletion'
* See Table 1 for footnotes.
times as large as that reproducing physiologic antidiuresis. They also dis-
covered that the in vitro dog adrenal is unresponsive to vasopressin.' These
studies warrant delay in the acceptance of Hilton's theory of direct adrenal
activation by the posterior pituitary.
In another experimental approach Sayers found that the administration of
0.5 to 5 units of pitressin to decapitated animals maintained by artificial
respiration resulted in ascorbic acid depletion. This was confirmed in 24-
hour hypophysectomized rats in which he injected 1 to 5 units of pitressin
and purified or synthetic arginine vasopressin.8' The significance of these
observations is obscure in light of Lipscomb's failure to demonstrate a
corticogenic effect of vasopressin upon the rat adrenal.
The coincidence of ADH and ACTH release. The second major tenet
of those who have postulated ADH as the mediator of ACTH discharge
by the pituitary is that the two hormones are released synchronously and
inhibited synchronously. Rothballer appears to have been the first to ad-
vance this argument. This investigator based his hypothesis on morpho-
logical evidence of depletion of granules (presumably ADH) from the
posterior pituitary to stimuli evoking ACTH discharge. Attention was
also directed to the similarity of stressors releasing the two hormones.'
424
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Mirsky, Stein, and Paulish published a series of experiments in which
they observed rapid variations of the antidiuretic activity of peripheral
blood following traumatic or emotional stresses. Working with the rat
they noted a 120 per cent rise in antidiuretic activity 30 seconds after ex-
posure to intense noise. A similar rise of activity was observed following
faradization or intraperitoneal injection of histamine. The administration of
cortisone or bilateral adrenalectomy produced changes in the level of anti-
diuretic substance which paralleled the alterations in ACTH release. In
addition they observed that changes in antidiuretic activity occur in hypo-
physectomized and adrenalectomized animals. These experiments were
interpreted as evidence that ADH may mediate ACTH release. The esti-
mates of antidiuretic activity by Mirsky et al. have been subject to criticism
by Van Dyke who found their assay method to be non-specific.' The obser-
vations of this group on the relationship between antidiuretic activity of
plasma and ACTH release are therefore of uncertain significance.
In an attempt to investigate the possible relationship of the two hormones,
Nichols et al. simultaneously studied the plasma corticoid and antidiuretic
responses of unanesthetized dogs to hypertonic saline injected into the
carotid artery. With these more direct criteria for hormone release no
correlation was demonstrable between antidiuresis and corticogenesis after
endogenous ADH release. Although the antidiuretic response varied from
moderate to maximal, elevation of plasma corticoids did not occur. Ad-
ditional observations made of plasma corticoids during ADH inhibition
by hydremia failed to show any parallel between the parameters.' Mac-
Donald has noted similar disassociations in the human.57
In recent work Dingman and his co-workers were able to selectively
stimulate the diencephalon of dogs producing either antidiuresis or ACTH
release as indicated by increased corticoid levels in the adrenal effluent
blood.'6
George and Way observed that whereas morphine induced both ACTH
and ADH release, only less than one hundredth of the dose was required
for stimulation of ADH discharge.' They found that the equivalent effect of
the larger ACTH-releasing morphine dose could be reproduced with aspirin
without any discharge of ADH.'
These data appear to justify the conclusion that ADH and ACTH are
independently released. The other side of the argument remains to be dis-
cussed. Are the two hormones blocked simultaneously? McCann and
Brobeck created electrocoagulative lesions of the hypothalamus in rats.'
These lesions, which inhibited normal adrenal ascorbic acid depletion to
stress, interrupted in each case the supraoptic-hypophyseal tract which
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Fisher et al. had shown to be essential for the release of ADH.1' The con-
sequent diabetes insipidus in these rats failing to respond to stress by the
release of ACTH was taken as strong evidence that ACTH release is
mediated by ADH. However, in rats with hypothalamic lesions adrenal
atrophy was not observed but rather adrenal hypertrophy which paralleled
the severity of diabetes insipidus.'
Using plasma corticosterone levels instead of adrenal ascorbic acid
depletion as an index of ACTH release, Nichols et al. reinvestigated this
apparent relationship. In a series of more than 600 rats minute hypothalamic
lesions were produced in the area of the median eminence. This lesion in-
hibited the stress response of plasma corticoids in about one fourth of the
animals. These animals also demonstrated diabetes insipidus in all but
very few cases. However, when the 303 animals with diabetes insipidus
are studied, only half of these demonstrated a block of ACTH release. It is
also noteworthy that in this series of animals demonstrating inability to
release ACTH adrenal atrophy was observed.' The discrepancy between
these observations and those of McCann may be due in part to the different
indices of ACTH release. However, others using adrenal ascorbic acid de-
pletion as the index of adrenal activation have also noted the lack of corre-
lation between ADH and ACTH blockade.6"6"" This discrepancy also
was noted in humans with diabetes insipidus who demonstrated no impair-
ment of the ACTH response to exercise.'
Observing the antidiuretic response in rats, de Wied and Mirsky found
that though prednisolone administration effectively inhibited the ACTH re-
lease following pain, or the injection of histamine or nicotine, the anti-
diuretic response to these stresses was intact.1' In contradistinction, McCann
et al. noted that hydrocortisone significantly, although incompletely, blocked
the antidiuresis following stress.' The apparent discrepancy does not eclipse
the major agreement that endogenous ADH can be released in the ani-
mal with effective steriod blockade of ACTH release. Gaunt, Lloyd,
and Chart found that hypothalamic antidiuretic activity was depleted
by stress and increased by hydrocortisone administration. Parallel changes
occurred in the posterior lobe antidiuretic activity except in the hydro-
cortisone treated animal where the material strikingly accumulated. The
changes in activity were reflected in changes in secretory morphology."
Schapiro et al. studied the urinary 17-OH steroid secretion in guinea pigs
and found that steriod production did not parallel the changes in anti-
diuretic activity of the hypothalamus or posterior pituitary.' This evidence
speaks against a physiological role of ADH in the regulation of ACTH re-
lease and also suggests that the level of endogenous adrenal steroids may
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never be sufficiently elevated to produce the ADH inhibiting effect seen with
exogenous steroids.
The effects of neurohypophysectomy on ACTH release. A direct approach
to the relationship between vasopressin and ACTH release has followed the
classic mode of endocrine study: ablation of the posterior lobe. The neuro-
hypophysectomized animal has been found refractory to stresses producing
ACTH discharge in normal animals. The results of these studies are sum-
TABLE 4. EFFECT OF NEUROHYPOPHYSECTOMY ON RESPONSE TO STRESS
Effective Blocked
stress stress Animal Index of response
Bell ringing Cold Rat Adrenal ascorbic acid
Pitressin Hypertonic depletion'
Nicotine saline
Epinephrine Rat Adrenal ascorbic acid
Electrical depletion2
shocking
Unilateral Cold (diminished) Rat Adrenal ascorbic acid
adrenalectomy Bell ringing depletion'
Epinephrine (IM, IV)
"Psychic stimuli" Rat Plasma free cortico-
(diminished) sterone"
Epinephrine Rat Plasma free cortico-
Epinephrine sterone. Adrenal as-
corbic acid depletion'0
Electrical Rat Plasma free cortico-
shocking sterone. Adrenal as-
Splenectomy corbic acid depletione0
marized in Table 4. One thing apparent from this table is the failure of
any investigator to find a complete block of ACTH discharge to all stressors.
In order to explain this finding, Nowell has postulated that only "systemic"
stresses are inhibited,n whereas Smelik and de Wied found only "psychic"
stimuli inhibited."' Fisher and De Salva noted that removal of the poste-
rior lobe resulted in apparent blockade of the adrenal ascorbic acid response
but not the corticosterone response to injected epinephrine.'
Nichols and Brodish studied both "psychic" and "systemic" stresses in the
neurohypophysectomized rat. They observed that the adrenal corticosteroid
response to stress was intact. When the adrenal ascorbic acid depletion was
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observed in these chronically stressed animals, the results were variable as
a consequence of observed elevations in ascorbic acid resting levels. There-
fore, it is again emphasized that the ascorbic acid depletion test cannot be
used reliab'y in the intact, chronically stressed rat.' Brodish and Long em-
phasized that the validity of the ascorbic depletion test is limited to the
hypophysectomized animal. Its use in intact animals leads to invalid inter-
pretations."
TABLE 5. THE INHIBITORY EFFECT OF VASOPRESSIN UPON STRESS*
Vasopressin Dose U. Animal Stress Index
Vasopressin 0.02-1%(SC) Mouse Cold Adrenal lipid depletion'
(DNZ) Epinephrine
Pituitrin 0.02-.04%(IV) Rat Pain Adrenal ascorbic acid
(DNZ) Cold depletion"
Pitressin 0.02%(IV) Rat Electrical Adrenal ascorbic acid
Synthetic LVP 0.02%(IV) shocking depletion and blood
Epinephrine ACTH (ascorbic acid
Laparotomy* depletion assay)2
Unilateral
adrenal-
ectomy*
Immobiliza-
tion*
Hypertonic Eosinophil depletion2
saline (SC)
*See Table 1 for footnotes.
Inhibition of ACTH release by exogenous ADH. Although major em-
phasis has been given to the stimulatory effects of vasopressin on ACTH
release, the material also possesses an ability to inhibit ACTH discharge from
the pituitary. The principal results of these experiments are summarized in
Table 5. Doses of 0.02 units inhibit various stresses when given to rats
and mice 30 minutes before the onset of the stress.1'" The mechanism of this
inhibition has been extensively studied by Arimura. This investigator found
that the timing of the pre-medication was critical, with deviations from the
30-minutes-before-stress schedule failing to inhibit the stress response. Syn-
thetic lysine vasopressin and pitressin were found to be equally effective.
With the dosage employed, there was no change in the hematocrit or in
the pituitary portal vessels when under direct observation. The phenomena
could not be the result of a refractory period following the administration
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of the premedication for small doses of epinephrine administered 30 minutes
before stress did not inhibit the response. Inactivated lysine vasopressin was
also without effect.2
The physiological role of these phenomena is not apparent but greater
significance should be attached to these observations for they occur with
doses of vasopressin which as Kurokawa has noted approach the physio-
logical level.'6
Itoh et al. found that hydrated rats were more responsive to stress and
that dehydration reduced the adrenal response to the same stresses: epine-
phrine, histamine, and cold. Under these conditions, no change in adrenal
sensitivity could be detected." Arimura observed that dehydration of
rats suppressed their response to electrical shocking and unilateral adrenalec-
tomy. In his hands hydration seemed to also suppress ACTH release al-
though producing hypertrophic adrenals.2 These observations in general
support the thesis of these investigators that ACTH may be inhibited by
ADH.
The significance of the ADH theory of ACTH release. In response to the
tenets of those who postulated that the antidiuretic hormone might be the
mediator of ACTH release, one can now reply that there is no parallelism
between release or inhibition of the two hormones. Only pharmacological
doses are capable of stimulating ACTH release, and the integrity of the
posterior pituitary or its hypothalamic projections is not necessary for
ACTH release.
What then is the significance of all the studies on ADH and ACTH in-
terrelationships? The evidence at hand does not exclude vasopressin from
the cast of supporting players. Just as the earlier theories of epinephrine
release and peripheral utilization of corticoids have been demonstrated to be
insufficient in their attempts to explain the full phenomenon of ACTH re-
lease; the ADH theory cannot account for the observed phenomena when
rigorous criteria are used. Just as epinephrine and push-pull theories have
remained part of a background of well-documented factors regulating the
pituitary-adrenal axis, the "vasopressin theory" will form part of our
understanding of ACTH physiology.
Several conclusions remain unquestioned about the relationship of the
antidiuretic hormone to ACTH release. The first is the ACTH releasing
activity of a large variety of preparations of the pressor material in a
variety of animal preparations as observed by all of the available criteria
for ACTH release (Table 1). The further observations that the ratio of
ACTH releasing activity to pressor activity is constant regardless of purifi-
cation,""7' the studies with purified or synthetic vasopressin, and the parallel
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inactivation of t-hese activities,' indicate that the activity is not due to a
contaminant. The action of vasopressin in animals blocked to stress indicates
a specificity of the effect on ACTH release (Table 2). These phenomena
are valuable contributions toan expanding field of pharmacology of peptides.
Another contribution of these studies is that they may give insight into
the nature of the physiological corticotrophin-releasing factor. It is tempting
to speculate, as has Guillemin, that the activity of exogenous vasopressin may
be due to a structural relationship to the physiological mediator of ACTH
release.=' " Indeed Schally et al. have found that their ACTH releasing
factor is closely related in size and amino acid composition but lacking in
vasopressin activity.'M
Although the evidence seems conclusive that ADH is not essential for
the stress response of ACTH, there are several indications that it may play
a more subtle role in regulating this anterior lobe hormone. That there is
a relationship between the pituitary-adrenal system and ADH is supported
by the excellent work of Gaunt et al. who found that hypothalamic anti-
diuretic activity varied inversely with plasma cortical hormone content.'
The studies of pituitary ACTH content by Fortier"' reveal that changes in
ACTH concentration parallel the hypothalamic antidiuretic activity ob-
served by Gaunt.
The inhibitory effect of ADH on ACTH release as demonstrated by
Arimura and other Japanese investigators may be another factor in the
background of the ACTH release story (Table 5). The fact that this phe-
nomenon is demonstrated with near-physiological doses and seems to be
quite specific in activity supports such a concept.
With these qualifications in mind it seems justified to relegate the ADH
theory of ACTH release to the emeritus role enjoyed by previous attempts
to explain this neural-glandular link in ACTH release. The contributions
of this theory have been both material and intellectual for it has stimulated
much of the present work in this field. Is not this sufficient justification for
these studies?
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